| Phenazopyridine Hydrochloride | |||
Symptomatic relief of pain, burning, urgency, frequency, and other discomforts resulting from irritation of the lower urinary tract mucosa caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters.
Use should not delay definitive diagnosis and treatment of cause; not a substitute for specific surgery or anti-infective therapy.
Used in combination with appropriate anti-infective agents for initial treatment (first 2 days) of uncomplicated urinary tract infections when pain, burning, or urgency relief is needed. However, there is lack of evidence that such combinations provide greater benefit than an anti-infective agent alone after 2 days; continue treatment after 2 days with anti-infective agent alone.
Also may be used for self-medication for the symptomatic relief of minor pain, urgency, frequency, and burning on urination.
Administer orally after meals.
Available as phenazopyridine hydrochloride; dosage expressed in terms of the salt.
12 mg/kg daily, in 3 divided doses.
Discontinue when pain and discomfort are relieved, usually after 3–15 days.
12 mg/kg daily, in 3 divided doses, for no more than 2 days; use in combination with an anti-infective agent and then continue therapy with anti-infective agent alone.
Usually, 200 mg 3 times daily.
Discontinue when pain and discomfort are relieved, usually after 3–15 days.
Usually, 200 mg 3 times daily for no more than 2 days; use in combination with an anti-infective agent and then continue therapy with anti-infective agent alone.
190 mg 3 times daily for up to 2 days.
Consult clinician if symptoms persist for >2 days.
Maximum 12 mg/kg daily, in 3 divided doses, for no more than 2 days.
Maximum 200 mg 3 times daily for no more than 2 days.
Maximum 190 mg 3 times daily for no more than 2 days.
Discontinue if yellowish color of the skin or sclerae occurs (may indicate accumulation resulting from renal impairment).
Urine may become orange to red in color, and may stain fabric; remove stains by soaking fabric in a 0.25% sodium dithionate or sodium hydrosulfite solution.
Discontinue and consult a clinician if pain and discomfort persist for longer than 2 days.
When used in fixed combination with other agents, consider the cautions, precautions, and contraindications associated with the concomitant agents.
Category B.
Not known whether phenzopyridine or metabolites are distributed into milk.
Contraindicated in severe hepatic impairment.
Possible accumulation of phenazopyridine; use is contraindicated.
![]() |
![]() |
